Funder
Instituto de Salud Carlos III
Catalonian Society of Digestology
Hospital Clinic
Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement
European Union
Reference33 articles.
1. EASL recommendations on treatment of hepatitis C 2018;Pawlotsky;J Hepatol,2018
2. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression;Waziry;J Hepatol,2017
3. AGA clinical practice update on interaction between oral direct-acting antivirals for chronic hepatitis C infection and hepatocellular carcinoma: expert review;Singal;Gastroenterology,2019
4. Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents;Wei;Expert Rev Anti Infect Ther,2019
5. Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysis;Galati;Expert Opin Drug Saf,2019
Cited by
153 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献